Glipizide
NDC 62559-315, Glipizide, tablet, from ANI Pharmaceuticals, Inc..
- Product NDC
- 62559-315
- Status
- Listed
- Labeler
- ANI Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA074497
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62559-315 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLIPIZIDE5 mg/1
Pharmacologic classes
Sulfonylurea Compounds [CS]; Sulfonylurea [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62559-315-10 | 62559031510 | 1000 TABLET in 1 BOTTLE (62559-315-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/252ba4e0-8dc3-43e3-be00-32570dc095bdNADAC price for package 62559031510
GET /v1/drugs/nadac/62559031510
Use it
Look up 62559-315 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62559-315 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62559-315. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.